172@29@17@249!~!172@29@0@53!~!|news|business|earnings|natco-pharma-consolidated-march-2020-net-sales-at-rs-454-80-crore-down-0-2-y-o-y-5421531.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Jun 18, 2020 10:05 AM IST | Source: Moneycontrol.com

Natco Pharma Consolidated March 2020 Net Sales at Rs 454.80 crore, down 0.2% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Natco Pharma are:

Net Sales at Rs 454.80 crore in March 2020 down 0.2% from Rs. 455.70 crore in March 2019.

Quarterly Net Profit at Rs. 94.10 crore in March 2020 down 22.1% from Rs. 120.80 crore in March 2019.

Close

EBITDA stands at Rs. 150.70 crore in March 2020 down 15.95% from Rs. 179.30 crore in March 2019.

Natco Pharma EPS has decreased to Rs. 5.17 in March 2020 from Rs. 6.59 in March 2019.

Natco Pharma shares closed at 614.00 on June 17, 2020 (NSE) and has given 5.40% returns over the last 6 months and 18.32% over the last 12 months.

Natco Pharma
Consolidated Quarterly Resultsin Rs. Cr.
Mar'20Dec'19Mar'19
Net Sales/Income from operations454.80482.20455.70
Other Operating Income------
Total Income From Operations454.80482.20455.70
EXPENDITURE
Consumption of Raw Materials107.8075.7079.10
Purchase of Traded Goods53.9034.407.50
Increase/Decrease in Stocks-66.80-18.60-19.60
Power & Fuel------
Employees Cost81.6097.8081.30
Depreciation30.5025.4021.70
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses150.00164.20159.10
P/L Before Other Inc., Int., Excpt. Items & Tax97.80103.30126.60
Other Income22.4030.8031.00
P/L Before Int., Excpt. Items & Tax120.20134.10157.60
Interest3.505.305.20
P/L Before Exceptional Items & Tax116.70128.80152.40
Exceptional Items------
P/L Before Tax116.70128.80152.40
Tax23.5024.4032.00
P/L After Tax from Ordinary Activities93.20104.40120.40
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period93.20104.40120.40
Minority Interest0.900.100.40
Share Of P/L Of Associates------
Net P/L After M.I & Associates94.10104.50120.80
Equity Share Capital36.4036.4036.50
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS5.175.756.59
Diluted EPS5.165.736.58
EPS After Extra Ordinary
Basic EPS5.175.756.59
Diluted EPS5.165.736.58
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

First Published on Jun 18, 2020 10:03 am
Sections